www.medical-devices.tech
28
'26
Written on Modified on
Software-Driven Radiotherapy System for Precision Oncology
Siemens Healthineers introduces Accela, a software-driven radiotherapy solution engineered around dynamic modulated arc therapy to scale complex cancer treatments.
www.siemens-healthineers.com
Siemens Healthineers introduces Accela, a software-driven radiotherapy solution engineered around dynamic modulated arc therapy to scale complex cancer treatments.
Technical Architecture and Dynamic Modulated Arc Therapy
The Accela radiotherapy solution is structured around NeoArc dynamic modulated arc therapy, a technique that integrates a high-speed gantry, a multi-leaf collimator, and higher dose rates.
- This architecture is designed to create conformal treatment plans while reducing delivery times.
- The system handles multi-site stereotactic body radiation therapy treatments in as little as sixty seconds.
- It enables single breath-hold stereotactic procedures that shorten patient table time.
Clinical Scalability and Workflow Integration
By accelerating treatment delivery and planning phases, the system addresses operational bottlenecks in radiation oncology departments. The technical integration aims to make complex stereotactic treatments more practical for high-volume cancer centers, allowing facilities to expand patient access without compromising delivery precision.
Additional Context:
This section details technical specifications and competitive benchmarking not included in the original product announcement
The Accela platform incorporates high-speed mechanical movement and advanced dose rate modulation to reduce temporal variations between imaging and beam delivery. Regulatory filings indicate that the system is a 510(k) pending device and is not commercially available in all markets.
Competitive benchmarking in modern linear accelerator-based stereotactic radiosurgery typically evaluates gantry rotation speed, multi-leaf collimator leaf positioning accuracy, and achievable monitor unit efficiency per degree of arc rotation. Systems utilizing dynamic arc delivery optimize these parameters to minimize intrafraction motion errors during single-fraction or hypofractionated stereotactic body radiation therapy.
Edited by Sucithra Mani, Induportals editor – adapted by AI.
www.siemens-healthineers.com
By accelerating treatment delivery and planning phases, the system addresses operational bottlenecks in radiation oncology departments. The technical integration aims to make complex stereotactic treatments more practical for high-volume cancer centers, allowing facilities to expand patient access without compromising delivery precision.
Additional Context:
This section details technical specifications and competitive benchmarking not included in the original product announcement
The Accela platform incorporates high-speed mechanical movement and advanced dose rate modulation to reduce temporal variations between imaging and beam delivery. Regulatory filings indicate that the system is a 510(k) pending device and is not commercially available in all markets.
Competitive benchmarking in modern linear accelerator-based stereotactic radiosurgery typically evaluates gantry rotation speed, multi-leaf collimator leaf positioning accuracy, and achievable monitor unit efficiency per degree of arc rotation. Systems utilizing dynamic arc delivery optimize these parameters to minimize intrafraction motion errors during single-fraction or hypofractionated stereotactic body radiation therapy.
Edited by Sucithra Mani, Induportals editor – adapted by AI.
www.siemens-healthineers.com
